目的探讨着丝粒蛋白W(centromere protein W,CENP-W)在人脑胶质瘤中的表达水平及与预后的相关性,并探讨其对脑胶质瘤细胞侵袭作用的影响。方法在高级别胶质瘤组织、低级别胶质瘤及瘤旁正常脑组织中,采用蛋白质印迹法、实时荧光定量PCR...目的探讨着丝粒蛋白W(centromere protein W,CENP-W)在人脑胶质瘤中的表达水平及与预后的相关性,并探讨其对脑胶质瘤细胞侵袭作用的影响。方法在高级别胶质瘤组织、低级别胶质瘤及瘤旁正常脑组织中,采用蛋白质印迹法、实时荧光定量PCR法检测CENP-W的表达水平,并统计分析表达水平与胶质瘤临床病理特征及预后的相关性,应用特异性siRNA干扰U251细胞中CENP-W表达使其下调后,通过Transwell侵袭实验观察转染CENPW siRNA对U251细胞侵袭能力的影响。结果胶质瘤组织CENP-W表达水平明显高于正常脑组织,并且与胶质瘤的病理级别呈正相关性;转染成功后,与空白对照组及阴性对照组比较,转染CENP-W-siRNA组的细胞侵袭及迁移能力均下降,Kaplan-Meier生存分析及Log-rank检验显示低表达CENP-W患者的PFS明显长于高表达组。结论CENP-W表达与胶质瘤的病理级别呈正相关,CENP-W可以促进脑胶质瘤的侵袭,预示CENP-W可作为胶质瘤治疗新靶点。展开更多
Pituitary adenomas（PAs） are well known as a common intracranial benign tumor, and a portion of PAs are refractory to current therapeutic methods. Erb B receptors family signaling pathway regulates the expression of ...Pituitary adenomas（PAs） are well known as a common intracranial benign tumor, and a portion of PAs are refractory to current therapeutic methods. Erb B receptors family signaling pathway regulates the expression of PAs activation associated gene. Inhibition of epidermal growth factor receptor（EGFR） can inhibit proliferation of PAs. Leucine-rich repeats and immunoglobulin-like domains protein 1（ LRIG1）, a negative mediated gene of Erb B receptors family, plays a role in many tumors. However, there are seldom researches about the functional role of LRIG1 in PAs. The aim of this study is to explore the potential effect of LRIG1 and its regulating mechanism in PAs. First, we investigated the role of LRIG1 in cell migration, invasion of PAs with transfected LRIG1 or control. Then, we explored its impact on cell proliferation and apoptosis of PAs in vivo. To study the regulating mechanism of LRIG1, we examined the expression of molecular factor of PI3K/AKT and Ras/Raf/ERK pathway using Western blotting in vitro and RT-PCR in vitro and in vivo. It was found that LRIG1 over-expression inhibited cell migration, invasion and proliferation, and promoted apoptosis of PAs in vivo and in vitro. Furthermore, LRIG1 suppressed the expression of signaling of PI3K/AKT and Ras/Raf/ERK pathways in PAs. LRIG1, as a negative mediated gene of tumor, can inhibit biological function of PAs via inhibiting PI3K/AKT and Ras/Raf/ERK pathways, and it might be a new target for gene therapy of PAs.展开更多
文摘目的探讨着丝粒蛋白W(centromere protein W,CENP-W)在人脑胶质瘤中的表达水平及与预后的相关性,并探讨其对脑胶质瘤细胞侵袭作用的影响。方法在高级别胶质瘤组织、低级别胶质瘤及瘤旁正常脑组织中,采用蛋白质印迹法、实时荧光定量PCR法检测CENP-W的表达水平,并统计分析表达水平与胶质瘤临床病理特征及预后的相关性,应用特异性siRNA干扰U251细胞中CENP-W表达使其下调后,通过Transwell侵袭实验观察转染CENPW siRNA对U251细胞侵袭能力的影响。结果胶质瘤组织CENP-W表达水平明显高于正常脑组织,并且与胶质瘤的病理级别呈正相关性;转染成功后,与空白对照组及阴性对照组比较,转染CENP-W-siRNA组的细胞侵袭及迁移能力均下降,Kaplan-Meier生存分析及Log-rank检验显示低表达CENP-W患者的PFS明显长于高表达组。结论CENP-W表达与胶质瘤的病理级别呈正相关,CENP-W可以促进脑胶质瘤的侵袭,预示CENP-W可作为胶质瘤治疗新靶点。
基金supported by grants from the National Natural Science Foundation of China(No.81560412)Jiangxi Provincial Health Development Planning Commission Project(No.20141065)Jiangxi Provincial Natural Science Foundation of China(No.20152BCB24009 and No.20151BDH80009)
文摘Pituitary adenomas（PAs） are well known as a common intracranial benign tumor, and a portion of PAs are refractory to current therapeutic methods. Erb B receptors family signaling pathway regulates the expression of PAs activation associated gene. Inhibition of epidermal growth factor receptor（EGFR） can inhibit proliferation of PAs. Leucine-rich repeats and immunoglobulin-like domains protein 1（ LRIG1）, a negative mediated gene of Erb B receptors family, plays a role in many tumors. However, there are seldom researches about the functional role of LRIG1 in PAs. The aim of this study is to explore the potential effect of LRIG1 and its regulating mechanism in PAs. First, we investigated the role of LRIG1 in cell migration, invasion of PAs with transfected LRIG1 or control. Then, we explored its impact on cell proliferation and apoptosis of PAs in vivo. To study the regulating mechanism of LRIG1, we examined the expression of molecular factor of PI3K/AKT and Ras/Raf/ERK pathway using Western blotting in vitro and RT-PCR in vitro and in vivo. It was found that LRIG1 over-expression inhibited cell migration, invasion and proliferation, and promoted apoptosis of PAs in vivo and in vitro. Furthermore, LRIG1 suppressed the expression of signaling of PI3K/AKT and Ras/Raf/ERK pathways in PAs. LRIG1, as a negative mediated gene of tumor, can inhibit biological function of PAs via inhibiting PI3K/AKT and Ras/Raf/ERK pathways, and it might be a new target for gene therapy of PAs.
